| Nanocapsule technology: a review P Couvreur, G Barratt, E Fattal, C Vauthier Critical Reviews™ in Therapeutic Drug Carrier Systems 19 (2), 2002 | 828 | 2002 |
| Poly (alkylcyanoacrylates) as biodegradable materials for biomedical applications C Vauthier, C Dubernet, E Fattal, H Pinto-Alphandary, P Couvreur Advanced drug delivery reviews 55 (4), 519-548, 2003 | 733 | 2003 |
| Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery P Calvo, B Gouritin, H Chacun, D Desmaele, J D'Angelo, JP Noel, ... Pharmaceutical research 18, 1157-1166, 2001 | 594 | 2001 |
| Hyaluronic acid for anticancer drug and nucleic acid delivery F Dosio, S Arpicco, B Stella, E Fattal Advanced drug delivery reviews 97, 204-236, 2016 | 547 | 2016 |
| Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting MT Peracchia, E Fattal, D Desmaele, M Besnard, JP Noel, JM Gomis, ... Journal of Controlled Release 60 (1), 121-128, 1999 | 531 | 1999 |
| Nanoparticulate systems for the delivery of antisense oligonucleotides G Lambert, E Fattal, P Couvreur Advanced drug delivery reviews 47 (1), 99-112, 2001 | 348 | 2001 |
| Pickering emulsions: Preparation processes, key parameters governing their properties and potential for pharmaceutical applications C Albert, M Beladjine, N Tsapis, E Fattal, F Agnely, N Huang Journal of Controlled Release 309, 302-332, 2019 | 326 | 2019 |
| Encapsulation of dexamethasone into biodegradable polymeric nanoparticles C Gómez-Gaete, N Tsapis, M Besnard, A Bochot, E Fattal International journal of pharmaceutics 331 (2), 153-159, 2007 | 321 | 2007 |
| “Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes E Fattal, P Couvreur, C Dubernet Advanced drug delivery reviews 56 (7), 931-946, 2004 | 272 | 2004 |
| Liposomes for intravitreal drug delivery: a state of the art A Bochot, E Fattal Journal of Controlled Release 161 (2), 628-634, 2012 | 259 | 2012 |
| Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications T Boissenot, A Bordat, E Fattal, N Tsapis Journal of Controlled Release 241, 144-163, 2016 | 241 | 2016 |
| Pore-forming peptides induce rapid phospholipid flip-flop in membranes E Fattal, S Nir, RA Parente, FC Szoka Jr Biochemistry 33 (21), 6721-6731, 1994 | 237 | 1994 |
| Liposomes and nanoparticles in the treatment of intracellular bacterial infections P Couvreur, E Fattal, A Andremont Pharmaceutical research 8, 1079-1086, 1991 | 237 | 1991 |
| Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides E Fattal, C Vauthier, I Aynie, Y Nakada, G Lambert, C Malvy, P Couvreur Journal of Controlled Release 53 (1-3), 137-143, 1998 | 226 | 1998 |
| Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides G Lambert, E Fattal, H Pinto-Alphandary, A Gulik, P Couvreur Pharmaceutical research 17, 707-714, 2000 | 225 | 2000 |
| Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells S Mura, H Hillaireau, J Nicolas, B Le Droumaguet, C Gueutin, S Zanna, ... International journal of nanomedicine, 2591-2605, 2011 | 219 | 2011 |
| Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading B Seijo, E Fattal, L Roblot-Treupel, P Couvreur International journal of pharmaceutics 62 (1), 1-7, 1990 | 211 | 1990 |
| Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization E Pisani, N Tsapis, J Paris, V Nicolas, L Cattel, E Fattal Langmuir 22 (9), 4397-4402, 2006 | 208 | 2006 |
| Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles E Fattal, M Youssef, P Couvreur, A Andremont Antimicrobial agents and chemotherapy 33 (9), 1540-1543, 1989 | 201 | 1989 |
| Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice M Shakweh, M Besnard, V Nicolas, E Fattal European Journal of Pharmaceutics and Biopharmaceutics 61 (1-2), 1-13, 2005 | 196 | 2005 |
Nicolas TsapisUniversité Paris-Saclay, Institut Galien Paris-Saclay, UMR CNRS 8612Verified email at universite-paris-saclay.fr
